Black Titan Corp (NASDAQ:BTTC) Sees Large Increase in Short Interest

Black Titan Corp (NASDAQ:BTTC) was the recipient of a large increase in short interest in the month of September. As of September 30th, there was short interest totaling 324,159 shares, an increase of 2,988.7% from the September 15th total of 10,495 shares. Approximately 6.5% of the shares of the company are sold short. Based on an average daily volume of 49,519,007 shares, the short-interest ratio is presently 0.0 days.

Black Titan Stock Performance

BTTC traded down $0.02 on Friday, hitting $0.48. 454,634 shares of the company traded hands, compared to its average volume of 4,384,786. Black Titan has a 12-month low of $0.34 and a 12-month high of $10.05. The company has a 50 day moving average of $0.55 and a 200-day moving average of $0.89. The company has a quick ratio of 4.62, a current ratio of 4.62 and a debt-to-equity ratio of 0.06. The stock has a market capitalization of $5.13 million, a PE ratio of -0.16 and a beta of 1.11.

About Black Titan

Titan Pharmaceuticals, Inc is a biopharmaceutical company developingproprietary therapeutics for the treatment of central nervous system disorders, cancer, and other serious and life threatening diseases. In the central nervous system arena, the company is developing iloperidone, which is clinical testing for schizophrenia through a licensing and development agreement with Novartis Pharma AG. Novartis has tradenamed the product Zomaril.